Bank of Montreal’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,000
Closed -$203K 5129
2019
Q3
$203K Sell
3,000
-20,881
-87% -$1.43M ﹤0.01% 2900
2019
Q2
$1.39M Buy
23,881
+1,342
+6% +$79.5K ﹤0.01% 1904
2019
Q1
$1.58M Sell
22,539
-3,010
-12% -$223K ﹤0.01% 1805
2018
Q4
$1.65M Sell
25,549
-13,305
-34% -$933K ﹤0.01% 1633
2018
Q3
$2.73M Buy
38,854
+4,202
+12% +$246K ﹤0.01% 1508
2018
Q2
$1.75M Sell
34,652
-2,268
-6% -$90K ﹤0.01% 1710
2018
Q1
$1.16M Sell
36,920
-1,276
-3% -$42.3K ﹤0.01% 1852
2017
Q4
$1.31M Sell
38,196
-795
-2% -$25.3K ﹤0.01% 1826
2017
Q3
$1.25M Sell
38,991
-4,114
-10% -$130K ﹤0.01% 1873
2017
Q2
$1.4M Sell
43,105
-12,072
-22% -$382K ﹤0.01% 1818
2017
Q1
$1.74M Sell
55,177
-11,290
-17% -$334K ﹤0.01% 1613
2016
Q4
$2.02M Buy
66,467
+59,247
+821% +$1.81M ﹤0.01% 1549
2016
Q3
$209K Hold
7,220
﹤0.01% 2450
2016
Q2
$187K Hold
7,220
﹤0.01% 2502
2016
Q1
$179K Hold
7,220
﹤0.01% 2525
2015
Q4
$254K Buy
7,220
+1,330
+23% +$35.6K ﹤0.01% 2284
2015
Q3
$125K Sell
5,890
-2,229
-27% -$57.4K ﹤0.01% 2504
2015
Q2
$226K Sell
8,119
-69
-0.8% -$1.95K ﹤0.01% 2355
2015
Q1
$250K Sell
8,188
-848
-9% -$27K ﹤0.01% 2263
2014
Q4
$289K Hold
9,036
﹤0.01% 2324
2014
Q3
$256K Sell
9,036
-400
-4% -$11.2K ﹤0.01% 2416
2014
Q2
$259K Sell
9,436
-778
-8% -$20.7K ﹤0.01% 2411
2014
Q1
$269K Buy
+10,214
New +$293K ﹤0.01% 2377

Bank of Montreal's GHDX Position: Q4 2019 in Review

Bank of Montreal sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,000 shares — an estimated $203K sold.

Bank of Montreal first reported a position in GHDX in Q1 2014 and held it in 23 quarters. The position peaked at $2.73M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • Bank of Montreal reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • Bank of Montreal sold 3,000 Genomic Health, Inc. shares in Q4 2019, an estimated $203K.
  • Bank of Montreal first reported a position in Genomic Health, Inc. in Q1 2014 and held it in 23 quarters.
  • Bank of Montreal's Genomic Health, Inc. position peaked at $2.73M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Bank of Montreal's 13F filing for Q4 2019, filed 10 Feb 2020.